Promis Neurosciences PMN
11.27
(0.30)
(2.59%)
as of 25 Sep
- Market cap
- $103.8M
- P/E
- 0.0×
Follow PMN
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(355.80%) | (521.60%) | (115.73%) | (172.30%) | |
| (127.40%) | (282.76%) | (100.21%) | (127.57%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(316.67%) | 3,230.77% | (68.84%) | (85.35%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(14.10) | (16.00) | (5.45) | (4.61) | |
Free Cash Flow |
(27.55) | (28.12) | (35.58) | (42.11) | |
| Other line items | |||||
Cash ROIC |
(111.91%) | (574.82%) | (28.56%) | (40.93%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.94 | 0.71 | 0.88 | 1.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(14.10) | (16.00) | (5.45) | (4.61) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates